By

moon
The EU-PEARL project aims to shape future drug development through a systematic approach that enables patient focused, cross company collaborative platform trials The EU Patient-cEntric clinicAl tRial pLatforms (EU-PEARL) is a unique public-private strategic partnership focused on creating a framework to set up adaptive clinical trial platforms of the future EU-PEARL hopes to transform clinical...
Read More
EU-PEARL kick-off meeting took place in November 21st and 22nd, 2019. Barcelona welcomed over 120 participants, in representation of EU-PEARL partners, associated collaborators, Innovative Medicines Initiative (IMI2) project officer and European Medicines Agency (EMA) The meeting served the purpose of aligning all members with the project’s objectives, work plan and interdependences which will allow EU-PEARL...
Read More
The Innovative Medicines Initiative has approved a 26 million euros project to advance in the development of a framework for platform trials. EU-PEARL aims to improve health outcomes for patients by transforming the way clinical trials are conducted. To this end, a strategic alliance between the public and private sector composed of 36 partners will...
Read More